Inactive Instrument

All News Nexus BioPharma, Inc.

Equities

Nexus BioPharma, Inc. Appoints Robert J. Neborsky, M.D. to Its Scientific and Clinical Advisory Board	17-08-10	CI
Nexus BioPharma, Inc. Auditor Raises 'Going Concern' Doubt	17-07-05	CI
Nexus BioPharma, Inc. announced that it has received $0.45 million in funding from JMJ Financial	17-03-07	CI
Nexus BioPharma, Inc. to License TransChem's Transition State Chemistry Technology for Kinase Inhibition	16-10-10	CI
Nexus BioPharma : Announces Agreement with TransChem for Kinase Inhibition Technology	16-10-07	PR
Nexus Seeks Acquisition	16-09-28	CI
Nexus BioPharma, Inc. : Appoints Helen Stefanovic as Director of Regulatory Affairs	16-09-22	PR
Nexus BioPharma, Inc. Appoints Helen Stefanovic as Director of Regulatory Affairs	16-09-22	CI
Nexus BioPharma, Inc. Auditor Raises 'Going Concern' Doubt	16-09-01	CI
Nexus BioPharma Corporation completed the acquisition of Nexus BioPharma, Inc. in a reverse merger transaction.	16-06-08	CI
Nexus BioPharma Corporation entered into an agreement of merger and plan of reorganization to acquire Nexus BioPharma, Inc. in a reverse merger transaction.	16-05-18	CI

No results for this search